Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wilkinson

Showing results (1101-1110 of 1,132) with videos related to

Pageof 114
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMsQiang Tan, Timothy A Blizzard, Jerry D Morgan, et al.
Plos One|August 14, 2013
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancersChloe I Bloom, Christine M Graham, Matthew P R Berry, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsMiguel Escobar, James Luck, Yevhenii Averianov, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
Genetic Epidemiology|June 4, 2009
Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studiesRobert J MacInnis, Antonis C Antoniou, Rosalind A Eeles, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitorsMiguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
Genetic Epidemiology|July 20, 2011
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impactRobert J Macinnis, Antonis C Antoniou, Rosalind A Eeles, et al.
Emerging Infectious Diseases|September 25, 2024
Population Structure and Antimicrobial Resistance in Campylobacter jejuni and C. coli Isolated from Humans with Diarrhea and from Poultry, East AfricaNigel P French, Kate M Thomas, Nelson B Amani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
Pageof 114

Showing results (1101-1110 of 1,132) with videos related to

Sort By:
Pageof 114
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMsQiang Tan, Timothy A Blizzard, Jerry D Morgan, et al.
Plos One|August 14, 2013
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancersChloe I Bloom, Christine M Graham, Matthew P R Berry, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsMiguel Escobar, James Luck, Yevhenii Averianov, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
Genetic Epidemiology|June 4, 2009
Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studiesRobert J MacInnis, Antonis C Antoniou, Rosalind A Eeles, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitorsMiguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
Genetic Epidemiology|July 20, 2011
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impactRobert J Macinnis, Antonis C Antoniou, Rosalind A Eeles, et al.
Emerging Infectious Diseases|September 25, 2024
Population Structure and Antimicrobial Resistance in Campylobacter jejuni and C. coli Isolated from Humans with Diarrhea and from Poultry, East AfricaNigel P French, Kate M Thomas, Nelson B Amani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
Pageof 114